PUBLISHER: TechNavio | PRODUCT CODE: 1693105
PUBLISHER: TechNavio | PRODUCT CODE: 1693105
The scar treatment market is forecasted to grow by USD 18.59 billion during 2024-2029, accelerating at a CAGR of 10.6% during the forecast period. The report on the scar treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising demand for non-invasive scar treatment procedures, increasing beauty consciousness among consumers, and increasing penetration of E-commerce channels.
Market Scope | |
---|---|
Base Year | 2025 |
End Year | 2029 |
Series Year | 2025-2029 |
Growth Momentum | Accelerate |
YOY 2025 | 9.2% |
CAGR | 10.6% |
Incremental Value | $18.59 bn |
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
Technavio's scar treatment market is segmented as below:
By Product
By Type
By End-user
By Geographical Landscape
This study identifies the increase in adoption of ambulatory surgery centers as one of the prime reasons driving the scar treatment market growth during the next few years. Also, increasing number of new launches and innovations in scar treatment drugs and devices and rise in medical tourism will lead to sizable demand in the market.
The report on the scar treatment market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading scar treatment market vendors that include Alliance Pharma PLC, Avita Medical Inc., Bayer AG, Biodermis LLC., Boston Scientific Corp., Candela Corp., CCA Industries Inc., Cynosure LLC, DEKA M.E.L.A. S.R.l., Johnson and Johnson Services Inc., Merz Pharma GmbH and Co KGaA, Molnlycke Health Care AB, Newmedical Technology Inc., Perrigo Co. PLC, Quantum Health, Scarguard Labs, Smith and Nephew PLC, Solta Medical, Sonoma Pharmaceuticals Inc., and Stratpharma AG. Also, the scar treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Exhibits: